BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6154097)

  • 1. Cross-reactive cytotoxic T cells to serologically distinct vesicular stomatitis virus.
    Rosenthal KL; Zinkernagel RM
    J Immunol; 1980 May; 124(5):2301-8. PubMed ID: 6154097
    [No Abstract]   [Full Text] [Related]  

  • 2. Elicitation and specificity of anti-vesicular stomatitis virus-specific cytotoxic T lymphocytes.
    Ruebush MJ; Hale AH; Lefrancois L; Harris DT; Burgess DE
    J Immunol; 1981 May; 126(5):2053-9. PubMed ID: 6260862
    [No Abstract]   [Full Text] [Related]  

  • 3. Cross-reactive anti-vesicular stomatitis virus (VSV) cytotoxic T lymphocytes recognize the major surface glycoprotein.
    Hale AH; Ruebush MJ; Lefrançois L
    Eur J Immunol; 1981 May; 11(5):434-6. PubMed ID: 6266837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of in vitro cytotoxic T cell clones directed against vesicular stomatitis virus.
    Rosenthal KL; Oldstone MB; Hengartner H; Zinkernagel RM
    J Immunol; 1983 Jul; 131(1):475-8. PubMed ID: 6190924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T lymphocytes reactive with vesicular stomatitis virus: analysis of specificity with monoclonal antibodies directed to the viral glycoprotein.
    Lefrancois L; Lyles DS
    J Immunol; 1983 Mar; 130(3):1408-12. PubMed ID: 6185583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesicular stomatitis antigens recognized by cytotoxic cells: analysis with defective interfering particles and reconstituted membrane vesicles.
    Ciavarra RP; Kang CY; Forman J
    J Immunol; 1980 Jul; 125(1):336-43. PubMed ID: 6247397
    [No Abstract]   [Full Text] [Related]  

  • 7. Inability of mice to generate cytotoxic T lymphocytes to vesicular stomatitis virus restricted to H-2Kk or H-2Dk.
    Rosenthal KL; Zinkernagel RM
    J Immunol; 1981 Feb; 126(2):446-51. PubMed ID: 6256440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of vesicular stomatitis virus major glycoprotein in determining the specificity of virus-specific and H-2-restricted cytolytic T cells.
    Sethi KK; Brandis H
    Eur J Immunol; 1980 Apr; 10(4):268-72. PubMed ID: 6249612
    [No Abstract]   [Full Text] [Related]  

  • 9. Minimal molecular and cellular requirements for elicitation of secondary anti-vesicular stomatitis virus cytotoxic T lymphocytes.
    Hale AH; Ruebush MJ
    J Immunol; 1980 Oct; 125(4):1569-77. PubMed ID: 6251135
    [No Abstract]   [Full Text] [Related]  

  • 10. Lysis of target cells infected with vesicular stomatitis virus (VSV) in the presence of tunicamycin by anti-VSV cytotoxic T lymphocytes.
    Harris DT; Hale AH; Lefrancois L
    J Immunol; 1981 May; 126(5):1914-8. PubMed ID: 6260860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vesicular stomatitis virus (VSV) infection on the development and regulation of T cell-mediated immune responses.
    Sy MS; Tsurufuji M; Finberg R; Benacerraf B
    J Immunol; 1983 Jul; 131(1):30-6. PubMed ID: 6190912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the target antigen of F1 anti-parent cytotoxic lympholysis: analysis of the spontaneous in vitro F1 cytotoxic T lymphocytes.
    Ishikawa H; Dutton RW
    J Immunol; 1980 Aug; 125(2):656-62. PubMed ID: 6967085
    [No Abstract]   [Full Text] [Related]  

  • 13. Augmentation of delayed-type hypersensitivity by vesicular stomatitis virus infection in mice.
    Katsura Y; Takaoki M; Kono Y; Minato N
    J Immunol; 1980 Oct; 125(4):1459-62. PubMed ID: 6157735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hapten-specific virus-replication T cells: analysis of the functional role in contact sensitivity.
    Takahashi C; Katsura Y
    J Immunol; 1980 Jun; 124(6):2721-7. PubMed ID: 6154737
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell-mediated immunity in flavivirus infections. I. Induction of cytotoxic T lymphocytes in mice by an attenuated virus from the tick-borne encephalitis complex and its group-reactive character.
    Gajdosová E; Oravec C; Mayer V
    Acta Virol; 1981 Jan; 25(1):10-8. PubMed ID: 6165230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superantigen-activated T cells redirected by a bispecific antibody inhibit vesicular stomatitis virus replication in vitro and in vivo.
    Fernandez-Sesma A; Peluso RW; Bai X; Schulman JL; Levy DE; Moran TM
    J Immunol; 1998 Feb; 160(4):1841-9. PubMed ID: 9469445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine specificity of cytotoxic T lymphocytes: C57BL effector cells induced by autologous cells modified with hapten (4-hydroxy-3-nitro-phenyl)acetyl (NIP) are not heteroclitic.
    Andó I; Kisielow P
    Eur J Immunol; 1979 Mar; 9(3):211-3. PubMed ID: 87325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The involvement of Lyt-2 antigens in the lysis of virus-infected target cells by antigen specific anti-vesicular stomatitis virus cytotoxic T-lymphocytes.
    Hale AH
    Immunol Lett; 1981 Aug; 3(3):179-81. PubMed ID: 6169636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interactionof antiody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies.
    Lefrancios L; Lyles DS
    Virology; 1982 Aug; 121(1):157-67. PubMed ID: 6180550
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of glycosylation in the H-2-restricted cytolysis of virus-infected cells.
    Black PL; Vitetta ES; Forman J; Kang CY; May RD; Uhr JW
    Eur J Immunol; 1981 Jan; 11(1):48-55. PubMed ID: 6260509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.